A Bird's Eye View Of Eagle Pharma
Shares of Eagle Pharmaceuticals Inc. (EGRX) are down 67% from their 52-week high of $40.85, recorded last November, and trade around $13. This commercial-stage pharmaceutical company specializes in oncology and acute care. Its marketed drugs include Belrapzo, Bendeka, Ryanodex, Treakisym, Pemfexy, Barhemsys and Byfavo. — Belrapzo is indicated for the treatment of patients with chronic lymphocytic leukemia.— Bendeka for the […]
Read more